header("Access-Control-Allow-Origin: *"); ?>
therapeuticpublished patents
oncologypublished patents
research tools
diagnosticpublished patents
Welcome to our Technology Offers website You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.
Diagnostic
Research
Therapeutic
Flow Cytometry
Immunocytochemistry
Immunoprecipitation
In vivo studies
Western Blot
Cardiovascular Diseases
Central Nervous System
Dermatology
Ear nose throat disease
Gastrointestinal Diseases
Genetic Disorders
Genito Urinary System
Hematological Disorders
Immunology
Musculoskeletal
Nutritional disorder
Oncology
Ophtalmology
Respiratory Disease
Women health
Others
Infectious diseases
The Bd37 is an erythrocyte binding protein anchored at the surface of the parasite Babesia divergens. B. divergens is an Apicomplexa parasite, mostly […]
We can offer and produce selective AEBS lignads for research purpose only.These compounds are potent inducers of breast cancer cell differentiation […]
Expression vectors encoding human cellular fibronectin variants harboring the alternatively spliced Extra Domains B and/or A (or neither) ; […]
Comprehensive inventory of 5,000 rare diseases, indexed with ICD10, OMIM, genes (HGNC nomenclature), swissprot, genatlas, class of prevalence, class […]
Directory of 5,000 ongoing academic research projects funded at national or European level in 36 countries, classified by disease and health product […]
PALM were generated by co-transfection of cervical cancer PC3 cells with the […]
MELN were generated by transfection of breasr cancer MCF-7 cells with the […]
HG5LN were generated by transfection of cervical cancer HeLa cells with the […]
HMLN were generated by transfection of cervical cancer HeLa cells with the MMTV- […]
HRLN were generated by transfection of cervical cancer HeLa cells with the […]
UG5LN were generated by transfection of osteocarcinoma cancer U2OS cells with the […]
UG5LN were generated by transfection of osteocarcinoma cancer U20S cells with the […]
UALH were generated by transfection of osteocarcinoma cancer U2OS cells with the […]
[…]
Mouse monoclonal antibody directed against mouse CCL5. Antibody was produced by immunising CCL5 […]